We are live on
!
Find out more
CCM
CAAS Capital Management Portfolio holdings
AUM
$934M
1-Year Est. Return
1.45%
This Fund
S&P 500
This Quarter
Est. Return
+26.63%
1 Year Est. Return
+1.45%
3 Year Est. Return
+10.99%
5 Year Est. Return
+150.62%
10 Year Est. Return
–
AUM
$10.5B
AUM Growth
+$6.2B
(+145%)
Cap. Flow
+$4.78B
Cap. Flow
% of AUM
45.54%
Top 10 Holdings %
Top 10 Hldgs %
28.07%
Holding
985
New
521
Increased
87
Reduced
60
Closed
171
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$153M |
| 2 |
Sunrun
RUN
|
+$94.3M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$83.8M |
| 4 |
Dynatrace
DT
|
+$67.2M |
| 5 |
Consolidated Edison
ED
|
+$56.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
First Solar
FSLR
|
+$71.8M |
| 2 |
10x Genomics
TXG
|
+$62.3M |
| 3 |
Caesars Entertainment
CZR
|
+$60.8M |
| 4 |
Denali Therapeutics
DNLI
|
+$53.1M |
| 5 |
PENN Entertainment
PENN
|
+$42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.01% |
| 2 | Healthcare | 6.25% |
| 3 | Communication Services | 2.7% |
| 4 | Consumer Discretionary | 2.07% |
| 5 | Financials | 1.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
CALL
Ciena
CIEN
$58.3B
| $4.04M | 0.04% |
76,500
| – | – |
|
|
352
PUT
Ciena
CIEN
$58.3B
| $4.04M | 0.04% |
76,500
| – | – |
|
353
GrowGeneration
GRWG
$89.5M
| $4.02M | 0.04% |
+100,000
| New | +$2.69M |
|
354
CALL
Pinterest
PINS
$13.1B
| $4M | 0.04% |
+60,700
| New | +$3.64M |
|
355
PUT
Enbridge
ENB
$114B
| $4M | 0.04% |
125,000
| – | – |
|
356
Clearway Energy Class C
CWEN
$4.87B
| $3.99M | 0.04% |
+124,972
| New | +$3.75M |
|
357
JD.com
JD
$44B
| $3.98M | 0.04% |
45,277
-435,670
| -91% | -$36.4M |
|
358
StepStone Group
STEP
$3.99B
| $3.98M | 0.04% |
100,000
| – | – |
|
359
Walmart Inc
WMT
$893B
| $3.97M | 0.04% |
+82,713
| New | +$4.02M |
|
360
PUT
Mondelez International
MDLZ
$79.5B
| $3.95M | 0.04% |
67,500
| – | – |
|
361
PUT
Visa
V
$688B
| $3.94M | 0.04% |
18,000
| – | – |
|
362
CALL
Vistra
VST
$47.5B
| $3.93M | 0.04% |
200,000
| – | – |
|
363
Dyne Therapeutics
DYN
$4.92B
| $3.9M | 0.04% |
185,911
+174,911
| +1,590% | +$3.46M |
|
364
Atara Biotherapeutics
ATRA
$77.5M
| $3.87M | 0.04% |
+7,883
| New | +$3.64M |
|
365
XPeng
XPEV
$11.3B
| $3.87M | 0.04% |
90,304
-109,696
| -55% | -$4.03M |
|
366
PUT
Spotify
SPOT
$100B
| $3.78M | 0.04% |
+12,000
| New | +$3.39M |
|
367
Wheaton Precious Metals
WPM
$55.8B
| $3.72M | 0.04% |
+89,100
| New | +$3.98M |
|
368
CALL
Norwegian Cruise Line
NCLH
$9.33B
| $3.69M | 0.04% |
+145,000
| New | +$3.03M |
|
|
369
PUT
Norwegian Cruise Line
NCLH
$9.33B
| $3.69M | 0.04% |
145,000
| – | – |
|
370
CALL
Pediatrix Medical
MD
$2.14B
| $3.68M | 0.04% |
150,000
| – | – |
|
371
PUT
Restaurant Brands International
QSR
$25.8B
| $3.67M | 0.04% |
60,000
| – | – |
|
|
AAN
372
DELISTED
The Aaron's Company Inc
AAN
| $3.64M | 0.03% |
+192,202
| New | +$3.54M |
|
373
PUT
Carnival Corporation Ltd
CCL
$40.7B
| $3.64M | 0.03% |
168,000
+140,000
| +500% | +$2.49M |
|
374
Prelude Therapeutics
PRLD
$364M
| $3.58M | 0.03% |
50,000
| – | – |
|
375
PUT
Palo Alto Networks
PANW
$297B
| $3.55M | 0.03% |
60,000
| – | – |
|
Similar funds
CIG
TAM
WCF
CHP
SWC
KTA
LC
SBIA
CAAS Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, CAAS Capital Management held 985 positions worth $10.5B, up 145% from $4.29B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
CAAS Capital Management deployed $4.78B of net new capital in Q4 2020, opening 521 new positions and adding to 87 existing holdings. Its largest new stake was Sunrun: 1,519,346 shares worth $105M.
By sector, the portfolio is most concentrated in Technology at 7% of assets, down from 7.8% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was First Solar, an estimated $71.8M trimmed.
- CAAS Capital Management's largest Q4 2020 buy was Sunrun: 1,519,346 shares worth $105M.
- CAAS Capital Management added most to Royalty Pharma in Q4 2020, an estimated $153M increase.
- CAAS Capital Management's biggest Q4 2020 reduction was First Solar, cutting an estimated $71.8M.
- CAAS Capital Management fully exited 10x Genomics in Q4 2020, selling an estimated $62.3M.
- CAAS Capital Management's ten largest holdings make up 28% of its $10.5B portfolio in Q4 2020.
- CAAS Capital Management opened 521 new positions and closed 171 in Q4 2020.
- CAAS Capital Management's portfolio value rose 145% quarter-over-quarter to $10.5B.
Based on CAAS Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.